Depression Pill Seems to Help Smokers Quit
Boston-- Taking an antidepression medicine appears to double smokers' chance of kicking the habit, a study found. The Food and Drug Administration approved the marketeing of this medicine, called Zyban or bupropion, to help smokers in May. The results of several studies with the drug, including one published in today's issue of the New England Journal of Medicine, were made public then. The newly published study involved 615 volunteers who wanted to give up smoking and were not outwardly depressed. They took either Zyban or dummy (placebo) pills for 6 weeks. A year later, 23% of those getting Zyban were still off cigarettes, compared to the 12% in the control group.

The results of this experiment were significant at the 0.05 significance level. In your opinion, are the results practically significant? Justify your position.

In performing a test of significance, the researcher can choose between adopting a fixed significance level or calculating a P-value. Does it matter which approach is taken? If so, describe the circumstances when one should use each approach.

Question

Depression Pill Seems to Help Smokers Quit
Boston-- Taking an antidepression medicine appears to double smokers' chance of kicking the habit, a study found. The Food and Drug Administration approved the marketeing of this medicine, called Zyban or bupropion, to help smokers in May. The results of several studies with the drug, including one published in today's issue of the New England Journal of Medicine, were made public then. The newly published study involved 615 volunteers who wanted to give up smoking and were not outwardly depressed. They took either Zyban or dummy (placebo) pills for 6 weeks. A year later, 23% of those getting Zyban were still off cigarettes, compared to the 12% in the control group.

The results of this experiment were significant at the 0.05 significance level. In your opinion, are the results practically significant? Justify your position.

In performing a test of significance, the researcher can choose between adopting a fixed significance level or calculating a P-value. Does it matter which approach is taken? If so, describe the circumstances when one should use each approach.

anonymous · Answer

@amistre64 @Hero @iambatman @inkyvoyd @Michele_Laino

anonymous · Answer

@campbell_st @nincompoop @Nnesha @AlexandervonHumboldt2